Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Cancer Discov. 2015 Oct 26;6(2):133–146. doi: 10.1158/2159-8290.CD-15-0583

Figure 3. Mesothelin-targeted immunotherapy strategies.

Figure 3

Several therapeutic strategies have been designed for targeting mesothelin on tumor cells (1) tumor vaccine strategy (2) antibody-based therapies (3) adoptive CAR T-cell therapy. These therapies are being evaluated in phase I and/or phase II clinical trials.